Research progress in traditional Chinese medicine in the treatment of Alzheimer's disease and related dementias

被引:32
作者
Tan, Wanying [1 ]
Qi, Lingjun [2 ]
Hu, Xiaoyu [1 ]
Tan, Zhenghuai [2 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
[2] Sichuan Acad Tradit Chinese Med, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; traditional Chinese medicine; ginseng; Pueraria lobata; epimedium; DANGGUI-SHAOYAO-SAN; BUYANG-HUANWU DECOCTION; GINKGO-BILOBA EXTRACT; KOREAN RED GINSENG; COGNITIVE IMPAIRMENT; MOUSE MODEL; DOWN-REGULATION; INDUCED NEUROTOXICITY; MEMORY IMPAIRMENTS; ADJUVANT TREATMENT;
D O I
10.3389/fphar.2022.921794
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease (AD) is the world's leading cause of dementia and has become a huge economic burden on nations and families. However, the exact etiology of AD is still unknown, and there are no efficient medicines or methods to prevent the deterioration of cognition. Traditional Chinese medicine (TCM) has made important contributions in the battle against AD based on the characteristics of multiple targets of TCM. This study reviewed the treatment strategies and new discoveries of traditional Chinese medicine in current research, which may be beneficial to new drug researchers.
引用
收藏
页数:24
相关论文
共 199 条
[1]   Danshensu attenuates scopolamine and amyloid-β-induced cognitive impairments through the activation of PKA-CREB signaling in mice [J].
Bae, Ho Jung ;
Sowndhararajan, Kandhasamy ;
Park, Hyeon-Bae ;
Kim, So-Yeon ;
Kim, Songmun ;
Kim, Dong Hyun ;
Choi, Ji Woong ;
Jang, Dae Sik ;
Ryu, Jong Hoon ;
Park, Se Jin .
NEUROCHEMISTRY INTERNATIONAL, 2019, 131
[2]   Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease [J].
Baum, Larry ;
Lam, Christopher Wai Kei ;
Cheung, Stanley Kwok-Kuen ;
Kwok, Timothy ;
Lui, Victor ;
Tsoh, Joshua ;
Lam, Linda ;
Leung, Vivian ;
Hui, Elsie ;
Ng, Chelsia ;
Woo, Jean ;
Chiu, Helen Fung Kum ;
Goggins, William B. ;
Zee, Benny Chung-Ying ;
Cheng, King Fai ;
Fong, Carmen Yuet Shim ;
Wong, Adrian ;
Mok, Hazel ;
Chow, Moses Sing Sum ;
Ho, Ping Chuen ;
Ip, Siu Po ;
Ho, Chung Shun ;
Yu, Xiong Wen ;
Lai, Caroline Yau Lin ;
Chan, Ming-Houng ;
Szeto, Samuel ;
Chan, Iris Hiu Shuen ;
Mok, Vincent .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) :110-113
[3]   "Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle [J].
Behl, Tapan ;
Kaur, Ishnoor ;
Sehgal, Aayush ;
Singh, Sukhbir ;
Sharma, Neelam ;
Makeen, Hafiz A. ;
Albratty, Mohammed ;
Alhazmi, Hassan A. ;
Felemban, Shatha Ghazi ;
Alsubayiel, Amal M. ;
Bhatia, Saurabh ;
Bungau, Simona .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 148
[4]   Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis [J].
Cai, Yawen ;
Chai, Yuhui ;
Fu, Yu ;
Wang, Yingdi ;
Zhang, Yiming ;
Zhang, Xue ;
Zhu, Lingpeng ;
Miao, Mingxing ;
Yan, Tianhua .
FRONTIERS IN AGING NEUROSCIENCE, 2022, 13
[5]   Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells [J].
Cao, Guoqiong ;
Su, Ping ;
Zhang, Shuai ;
Guo, Limin ;
Zhang, Haijing ;
Liang, Yuexia ;
Qin, Chunxia ;
Zhang, Wensheng .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 793 :101-108
[6]  
Chen C., 2017, EFFECT LONG TERM ADM
[7]  
Chen Qin, 2015, Zhongguo Zhong Xi Yi Jie He Za Zhi, V35, P327
[8]  
Chen Y., 2013, TIANJIN J TRADITIONA, V30, P40, DOI [10.11656/j.issn.1672-1519.2013.01.14, DOI 10.11656/J.ISSN.1672-1519.2013.01.14]
[9]   Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance [J].
Chen, Ying ;
Chen, Yuling ;
Liang, Yubin ;
Chen, Hongda ;
Ji, Xiaoying ;
Huang, Min .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
[10]  
[陈紫微 Chen Ziwei], 2020, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V43, P569